[EN] LIPOTHIOPHOSPHORAMIDATES FOR GENE DELIVERY<br/>[FR] LIPOTHIOPHOSPHORAMIDATES POUR L'ADMINISTRATION DE GÈNES
申请人:UNIV BRETAGNE OCCIDENTALE
公开号:WO2012045797A1
公开(公告)日:2012-04-12
The disclosure refers to cationic lipothiophosphoramidates for in vitro and in vivo gene delivery, to the use thereof for gene delivery, as well as to liposomes and lipoplexes comprising such cationic lipothiophosphoramidates and to a method for preparing such cationic lipothiophosphoramidates.
of the DNA binding ability of the liposomes have completed the physico-chemical characterizations of the cationiclipids studied. Finally, the cationiclipids 3a–b and 7a–c have been evaluated as synthetic vectors for gene transfection into a variety of mammaliancell lines. The lipo-thiophosphoramidate 7a proved to be an efficient and low toxicity synthetic vector even when used at low lipid to DNA